Gene Therapy upstream processing: adherent vs suspension cost modelling and perspectives

 

There is huge pressure on biomanufacturing facilities due to high demand for gene therapy products such as recombinant adeno-associated viral (AAV) vectors made under current good manufacturing practice (GMP) conditions. The constraints of the scale-up process are rarely taken into consideration during clinical process development, with many facilities simply scaling-out adherent cell stack protocols, procedures, and test methods. In order to demonstrate the importance of cost economics linked to the choice of scale-up processes, this study provides a detailed cost modeling analysis comparing viral vector production in adherent cells in cell stacks to viral vectors produced in bioreactors, either in suspension using a stirred bioreactor or adherently in iCELLis® fixed-bed bioreactor.

Speaker

Meriem Bendouma

Business Development Manager

Pall


Graduated from École Nationale d’Agronomie et des Industries Alimentaires in France, with a specialty in Bioprocessing. She first worked in mAbs development for diagnostic applications. She held different positions within PALL, including project manager for automated purification systems, bioprocess specialist, and now business development manager.

Complete the form below to watch the webinar now
More webinars coming!
Check box below for updates
By clicking the "Watch Now" button below and proceeding I confirm that I have reviewed and agree with the terms of use and privacy policy.

Choose Your Culture System for Viral Vector Production with Confidence!

Listen to our Podcast Today and Learn the Advantages, Challenges and Cost Considerations for Adherent and Suspension Cell Cultures.

 

More Biotech Webinars
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
January 2022
Gene Therapy Downstream Manufacturing, Scale-up and Best Practices

Biotech | Pall Corporation webinar series

Meet the authors from the ‘Insights on Successful Gene Therapy Manufacturing and Commercialization’ ebook

Watch